MitoQ Limited is a New Zealand-based company focused on cellular health, headquartered in Auckland. It specializes in mitochondrial supplements that enhance healthspan, vitality, metabolic health, energy, exercise recovery, resilience, and healthy aging. Founded on technology from the University of Otago, MitoQ developed a proprietary molecule called MitoQ, which is a targeted antioxidant that supports mitochondria and reduces cell stress. The company holds 60 global patents and has its benefits validated by numerous clinical trials and research papers.
MitoQ offers a range of cellular health products featuring its unique MitoQ ingredient, aimed at improving cellular function for all users, not just athletes. The company has recently rebranded to emphasize "Positive Selfism," promoting a positive impact on individuals and their communities. With a team of approximately 72 employees, MitoQ is positioned as a leader in the cellular health category, targeting health-conscious consumers in markets like the U.S. and China.
Developer of nootropic-focused nutrition supplements intended to help people achieve their full potential through a happier and healthier brain. The company offers a wide range of practitioner-formulated products that target specific ailments and physiological pathways that impact brain health and cognitive function, including inflammation, gut-brain axis, mitochondrial function, detoxification, and sleep deprivation, enabling users to achieve long-term and sustainable neurological, physiological and metabolic wellbeing.